GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues – “Open Labs, Open Minds” (B) Harvard Case Solution & Analysis

In January 2010, Andrew Witty understood that the Pharmaceutical Patent Pool in and of itself was not sufficient to generate actions on neglected tropical diseases. He declared, therefore the "Open Labs, Open Minds" strategy. Was this enough to support action for neglected diseases affecting the world's lowest? How would the shareholders of GSK react?

PUBLICATION DATE: March 08, 2011 PRODUCT #: W10016-PDF-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Related Case Solutions & Analyses:

McDonald’s India The Banyan Tree: Branding the intangible Otis Elevator KFC China: Still “Finger Lickin’ Good?” 6 Items for the Top of Every Board’s Agenda Billy Beane and the Oakland Athletics (B): Advanced Metrics Beyond Baseball Robert Mandavi and The Wine Industry Employee Handbook McDonald’s Twitter Campaign: Hype Versus Reality China: A Concise Profile, 2014